milnacipran hydrochloride

FDA Drug Profile — Savella, Milnacipran Hydrochloride

Drug Details

Generic Name
milnacipran hydrochloride
Brand Names
Savella, Milnacipran Hydrochloride
Application Number
NDA022256
Sponsor
Cardinal Health 107, LLC
NDC Codes
14
Dosage Forms
TABLET, FILM COATED, KIT
Routes
ORAL
Active Ingredients
MILNACIPRAN HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE FETZIMA ® is indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )]. Limitation of Use: FETZIMA is not approved for the management of fibromyalgia. The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established. FETZIMA is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD) in adults ( 1 ). Limitation of Use : FETZIMA is not approved for the management of fibromyalgia. The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established ( 1 ).